Temporal Sensitivity Measured Shortly After Cochlear Implantation Predicts 6-Month Speech Recognition Outcome.


Journal

Ear and hearing
ISSN: 1538-4667
Titre abrégé: Ear Hear
Pays: United States
ID NLM: 8005585

Informations de publication

Date de publication:
Historique:
pubmed: 27 4 2018
medline: 19 4 2019
entrez: 27 4 2018
Statut: ppublish

Résumé

Psychoacoustic tests assessed shortly after cochlear implantation are useful predictors of the rehabilitative speech outcome. While largely independent, both spectral and temporal resolution tests are important to provide an accurate prediction of speech recognition. However, rapid tests of temporal sensitivity are currently lacking. Here, we propose a simple amplitude modulation rate discrimination (AMRD) paradigm that is validated by predicting future speech recognition in adult cochlear implant (CI) patients. In 34 newly implanted patients, we used an adaptive AMRD paradigm, where broadband noise was modulated at the speech-relevant rate of ~4 Hz. In a longitudinal study, speech recognition in quiet was assessed using the closed-set Freiburger number test shortly after cochlear implantation (t0) as well as the open-set Freiburger monosyllabic word test 6 months later (t6). Both AMRD thresholds at t0 (r = -0.51) and speech recognition scores at t0 (r = 0.56) predicted speech recognition scores at t6. However, AMRD and speech recognition at t0 were uncorrelated, suggesting that those measures capture partially distinct perceptual abilities. A multiple regression model predicting 6-month speech recognition outcome with deafness duration and speech recognition at t0 improved from adjusted R = 0.30 to adjusted R = 0.44 when AMRD threshold was added as a predictor. These findings identify AMRD thresholds as a reliable, nonredundant predictor above and beyond established speech tests for CI outcome. This AMRD test could potentially be developed into a rapid clinical temporal-resolution test to be integrated into the postoperative test battery to improve the reliability of speech outcome prognosis.

Identifiants

pubmed: 29697465
doi: 10.1097/AUD.0000000000000588
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-33

Auteurs

Julia Erb (J)

Max Planck Research Group "Auditory Cognition", Max Planck Institute for Cognitive and Brain Sciences, Leipzig, Germany.
Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Department of Psychology, University of Lübeck, Lübeck, Germany.

Alexandra Annemarie Ludwig (AA)

Department of Otorhinolaryngology, Section Phoniatrics and Audiology, University Clinic of Leipzig, Leipzig, Germany.
Faculty of Biosciences, Pharmacy and Psychology, Institute for Biology, University of Leipzig, Leipzig, Germany.

Dunja Kunke (D)

Max Planck Research Group "Auditory Cognition", Max Planck Institute for Cognitive and Brain Sciences, Leipzig, Germany.

Michael Fuchs (M)

Department of Otorhinolaryngology, Section Phoniatrics and Audiology, University Clinic of Leipzig, Leipzig, Germany.
Cochlea-Implant-Center Leipzig, Leipzig, Germany.

Jonas Obleser (J)

Max Planck Research Group "Auditory Cognition", Max Planck Institute for Cognitive and Brain Sciences, Leipzig, Germany.
Department of Psychology, University of Lübeck, Lübeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH